A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
Durability of vaccine-induced and natural immunity against COVID-19: a narrative review
N Pooley, SS Abdool Karim, B Combadière… - Infectious Diseases and …, 2023 - Springer
Vaccines developed against SARS-CoV-2 have proven to be highly effective in preventing
symptomatic infection. Similarly, prior infection with SARS-CoV-2 has been shown to provide …
symptomatic infection. Similarly, prior infection with SARS-CoV-2 has been shown to provide …
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis …
Background Synthesising evidence on the long-term vaccine effectiveness of COVID-19
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
COVID-19 vaccine uptake among healthcare workers: a systematic review and meta-analysis
The vaccine-induced immunity of healthcare workers (HCWs) is crucial to controlling the
COVID-19 pandemic. Therefore, we conducted a systematic review and meta-analysis to …
COVID-19 pandemic. Therefore, we conducted a systematic review and meta-analysis to …
Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts
SARS-CoV-2 infection in children and young people (CYP) can lead to life-threatening
COVID-19, transmission within households and schools, and the development of long …
COVID-19, transmission within households and schools, and the development of long …
Waning immunity to SARS-CoV-2 following vaccination or infection
C Hernandez-Suarez, E Murillo-Zamora - Frontiers in Medicine, 2022 - frontiersin.org
We use survival analysis to analyze the decay in the protection induced by eight SARS-CoV-
2 vaccines using data from 33,418 fully anonymized patients from the IMSS public health …
2 vaccines using data from 33,418 fully anonymized patients from the IMSS public health …
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self …
Background Post-authorisation vaccine safety surveillance is well established for reporting
common adverse events of interest (AEIs) following influenza vaccines, but not for COVID-19 …
common adverse events of interest (AEIs) following influenza vaccines, but not for COVID-19 …
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS‐Cov-2 B. 1.1. 529 (Omicron) variant
Abstract The B. 1.1. 529 (Omicron) variant surge has raised concerns about the
effectiveness of vaccines and the impact of imprudent reopening. Leveraging over two years …
effectiveness of vaccines and the impact of imprudent reopening. Leveraging over two years …
Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
L Reynolds, C Dewey, G Asfour, M Little - Frontiers in Public Health, 2023 - frontiersin.org
The purpose of this systematic review was to report on the vaccine efficacy (VE) of three
SARS-CoV-2 vaccines approved by Health Canada: Pfizer BioNTech, Moderna, and …
SARS-CoV-2 vaccines approved by Health Canada: Pfizer BioNTech, Moderna, and …